BioNumerik Pharmaceuticals, Inc.
🏢 View company profile →91Patents
18Active
91Granted
37Portfolio score
Filing activity: Dec 22, 1993 → May 1, 2014 · 14 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5726181A | Formulations and compositions of poorly water soluble camptothecin derivatives | Human Necessities | 79 | Expired |
| US6040330A | Pharmaceutical formulations of taxanes | Human Necessities | 53 | Expired |
| US5919816A | Formulations and methods of reducing toxicity of antineoplastic agents | Human Necessities | 48 | Expired |
| US5859022A | Formulations and compositions of poorly water soluble camptothecin derivatives | Human Necessities | 35 | Expired |
| US5447936A | Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof | Human Necessities | 29 | Expired |
| US5468754A | 11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof | Human Necessities | 28 | Expired |
| US5789000A | Sterile aqueous parenteral formulations of cis-diammine dichloro platinum | Human Necessities | 26 | Expired |
| US5910491A | Highly lipophilic camptothecin derivatives | Emerging Cross-Sectional Technologies | 24 | Expired |
| US6057303A | Highly lipophilic Camptothecin derivatives | Human Necessities | 20 | Expired |
| US5902610A | Formulations and methods of use of 2,2'-dithio-bis-ethane sulfonate | Human Necessities | 18 | Expired |
| US7759488B2 | Monoazole ligand platinum analogs | Human Necessities | 17 | Active |
| US7235589B2 | Method of treating patients undergoing kidney dialysis | Human Necessities | 16 | Expired |
| US5674874A | Lactone stable formulation of 7-ethyl 10-hydroxy camptothecin and methods for uses thereof | Human Necessities | 15 | Expired |
| US8026227B2 | Chemoprotective methods and compositions | Human Necessities | 15 | Active |
| US6028078A | Highly lipophilic camptothecin derivatives | Emerging Cross-Sectional Technologies | 12 | Expired |
| US6075053A | Method of reducing or reversing neuropathy | Human Necessities | 12 | Expired |
| US5597829A | Lactone stable formulation of camptothecin and methods for uses thereof | Human Necessities | 12 | Expired |
| US6066668A | Formulations and methods of reducing toxicity of antineoplastic agents | Human Necessities | 11 | Expired |
| US5935967A | Pharmaceutical formulations of highly lipophilic camptothecin derivatives | Human Necessities | 11 | Expired |
| US5604233A | Lactone stable formulation of 7-ethyl camptothecin and methods for uses thereof | Human Necessities | 10 | Expired |
| US6057361A | Formulations and methods of reducing toxicity of antineoplastic agents | Human Necessities | 10 | Expired |
| US5866617A | Formulations and methods of use 2,2'-dithio-bis-esthane sulfonate | Human Necessities | 10 | Expired |
| US5674873A | Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof | Human Necessities | 9 | Expired |
| US5859023A | Formulations and compositions of poorly water soluble camptothecin derivatives | Human Necessities | 9 | Expired |
| US5880133A | Pharmaceutical formulations of highly lipophilic camptothecin derivatives | Human Necessities | 9 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.